Successful MDR Certification for AI Solution in Predicting Postoperative Complications – New Product Generation for Optimized Patient Safety

Share

Berlin, October 2, 2024

x-cardiac, a leader in AI-based medical devices for the prediction of postoperative complications after cardiac surgery, is pleased to announce the successful MDR (Medical Device Regulation) certification of its new x-cardiac-platform. This certification introduces a completely new generation of products offering state-of-the-art technologies to optimize patient care and safety.

The x-cardiac-platform is an innovative tool in the field of digital biomarkers and is specifically designed to increase patient safety and treatment quality in critical situations. With the successful MDR certification, the platform fulfills the strictest European requirements for safety and performance and thus marks a significant milestone in medical technology.

The new product generation includes two innovative plug-ins: x-c-bleeding and x-c-renal-injury. These plug-ins offer unprecedented support in the detection and treatment of bleeding and kidney damage after major heart surgery.

“With the new product generation, we can offer completely new possibilities for predicting postoperative complications in everyday clinical practice, which we will now increasingly promote beyond Germany, Austria, and Switzerland, also with sales partners,” says Oliver Höppner, CEO of x-cardiac. “With the x-cardiac platform, we are offering users a powerful medical device that can make a lasting difference in patient care. We are looking forward to the upcoming EACTS Annual Summit 2024 (European Association for Cardio-Thoracic Surgery) from October 10-12 in Lisbon, where we plan to present our new product generation to the professional audience.”

Chief Medical Officer Prof. Dr. Alexander Meyer on the new product generation: “The x-cardiac-platform sets new standards in the clinical care of patients by performing local validation of the algorithms for each customer. This enables us to ensure that our solutions are optimally tailored to individual needs and circumstances. Optional fine tuning allows us to customize the models to deliver even more precise results.”

Contacts

Oliver Höppner
x-cardiac GmbH
presse@xcardiac.com
www.xcardiac.com

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Competition is on for the CIVIS Media Prize 2025: Submissions possible until 12 December 202431.10.2024 10:30:00 CET | Press Release

31.10.2024 – Köln (ots) | The competition for the European CIVIS Media Prize is on. Until 12 December 2024, media professionals from all EU countries and Switzerland can submit entries online on the topics of migration, integration, cultural diversity and related issues of social cohesion. The CIVIS Media Prize honours outstanding achievements in television, radio, internet and social media that promote the peaceful coexistence of people from different geographical and cultural backgrounds. It is endowed with a total of 27,000 euros. Nine CIVIS AWARDS are awarded in various categories. Further information on the CIVIS Media Prize 2025 can be found here. Click here to register. The CIVIS Media Prize is sponsored by ARD, represented by WDR, together with the Freudenberg Foundation. ORF, SRG SSR, ARTE, 3sat, Deutsche Welle, Deutschlandradio and EBU are media partners. WDR mediagroup, the Allianz Deutscher Produzentinnen und Produzenten – Film, TV und Audiovisuelle Medien e.V., the Verwert

eM Client Acquires Postbox Inc., Expanding Its Reach to a Broader User Base23.10.2024 11:08:58 CEST | Pressmeddelande

The acquisition solidifies eM Client’s position as a leading email client provider, bringing its innovative solutions to a growing audience. Prague, October 23, 2024 – eM Client, a leading provider of email client software, announced its acquisition of Postbox Inc., a well-established email application company based in the United States. This acquisition enables eM Client to extend its innovative solutions to an even larger global audience, reinforcing its position as one of the most comprehensive email platforms available. Summary: Who: eM Client has acquired Postbox Inc. What: The acquisition expands eM Client’s reach to a broader user base. When: October 22, 2024. Where: eM Client is based in Prague and serves a global customer base. Why: The acquisition strengthens eM Client’s leadership in the email client industry and brings its powerful tools to more users. eM Client has established itself as a top choice for email users, integrating email, calendars, contacts, tasks, and notes

First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist22.10.2024 13:11:31 CEST | Pressmeddelande

Aachen, Germany, 22 October 2024 – Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the pharmacokinetic characteristics of the compound after single and multiple ascending doses. The results of the trial are expected in Q3 2025. “Grünenthal pioneered the research into NOP receptor agonists to deliver a unique and transformative first-in-class therapy option to millions of patients suffering from chronic pain,” says Gillian Burgess, Head of Research, Grünenthal. “With a unique mechanism of action for treating chronic pain, these molecules have the potential to deliver robust pain relief combined with an improved safety profile compared to the available standard of care.” Pre-clinical data show that NOP receptor agonists have the potential to act as pot

PIONIERKRAFT raises a high seven-figure amount in Series A financing round from climate tech investor First Imagine!21.10.2024 16:15:31 CEST | Press Release

Munich, 21 October 2024 Munich-based energy start-up PIONIERKRAFT has raised a high seven-figure amount in its Series A financing round, led by First Imagine!, a European venture capital firm focused on innovative solutions for a sustainable future. With this investment, PIONIERKRAFT will expand its energy-sharing solution for apartment buildings. "When we founded PIONIERKRAFT in 2019, we saw an opportunity to build a foundation for the energy transition in small and medium-sized apartment buildings," says Andreas Eberhardt, CEO of PIONIERKRAFT. "This funding will help us scale our network of partners and ramp up mass production of our energy-sharing solution." First Imagine! recognizes PIONIERKRAFT's growth potential and aims to accelerate the renewable energy transition. "Partnering with PIONIERKRAFT allows us to address the large sector of multi-tenant buildings in Germany that has been excluded from rooftop solar installations," says Alexander Starchenko, Managing Partner of First

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye